Senseonics Publishes Positive Longitudinal Performance Over Multiple Sensor Insertions and Removal Cycles of the Eversense® CGM System

GERMANTOWN, Md.–(BUSINESS WIRE)–Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and commercialization of the first and only long-term, implantable continuous glucose monitoring (CGM) system for people with diabetes, announced the publication of an assessment of the performance of multiple sequential cycles of Eversense 90 and 180-day CGM System use … [Read more…]

Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference

NORTH BILLERICA, Mass.–(BUSINESS WIRE)–Lantheus Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus Medical Imaging, Inc. (“LMI”), a global leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced Mary Anne Heino, President and Chief Executive Officer, will participate in a fireside chat at the 31st Annual … [Read more…]

NextGen Healthcare to Host Annual Investor and Analyst Day on Thursday, December 12, 2019

IRVINE, Calif.–(BUSINESS WIRE)–NextGen Healthcare, Inc. (NASDAQ: NXGN) will host its annual Investor and Analyst Day on Thursday, December 12, 2019, in New York City from 1:00 p.m. to 3:30 p.m, with lunch and registration beginning at 12:30 p.m. This event is designed for sell-side research analysts and institutional investors and will focus on the Company’s … [Read more…]

Exactech Expands Global Direct Operations with Acquisition of Italian Distributor

GAINESVILLE, Fla.–(BUSINESS WIRE)–Exactech, a developer and producer of innovative implants, instrumentation and computer-assisted technologies for joint replacement surgery announced today the acquisition of its independent distribution partner, Exactech Italia S.p.A., creating a new corporate subsidiary, effective Nov. 21, 2019. The purchase included all shares of the Province of Brescia-based importer and distributor of Exactech’s orthopaedic … [Read more…]

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Fourth Quarter and Year Ended September 30, 2019

Webcast and Conference Call today at 4:30 p.m. ET Initiation of RSVP, a Phase 2b study of EDP-938 in adult outpatients with RSV EDP-297 selected as follow-on FXR agonist with differentiated preclinical profile Royalty revenue for the quarter was $51.3 million Cash and marketable securities totaled approximately $400 million at September 30, 2019 WATERTOWN, Mass.–(BUSINESS … [Read more…]

Klick Health Welcomes Carl Turner as Chief Brand Strategy Officer

Large independent agency announces latest senior hire in series of moves that support ongoing growth and build for the future TORONTO & NEW YORK–(BUSINESS WIRE)–Klick Health today announced that seasoned healthcare marketing strategist Carl Turner has joined its growing team as Chief Brand Strategy Officer in a move that will help cement the independent hypergrowth … [Read more…]

CALQUENCE Approved in the US for Adult Patients With Chronic Lymphocytic Leukemia

Two Phase III CALQUENCE trials demonstrated superior progression-free survival across multiple settings while maintaining favorable tolerability CALQUENCE combined with obinutuzumab and as monotherapy reduced the risk of disease progression or death by 90% and 80%, respectively in ELEVATE-TN WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved CALQUENCE® (acalabrutinib) … [Read more…]

Life Spine Announces FDA 510(k) Clearance of the Award-winning LONGBOW® Titanium Lateral Expandable Spacer System

HUNTLEY, Ill.–(BUSINESS WIRE)–Life Spine, a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spinal disorders, announced today that it has received clearance from the U.S. Food & Drug Administration (FDA) to market the LONGBOW Titanium Lateral Expandable Spacer System. “We are thrilled to be releasing a Titanium version … [Read more…]

BRUKINSA™ (zanubrutinib) Approved for the Treatment of Mantle Cell Lymphoma, Available from Onco360

LOUISVILLE, Ky.–(BUSINESS WIRE)–Onco360®, the nation’s largest independent Oncology Pharmacy, has been selected by BeiGene to be a specialty pharmacy network partner for BRUKINSA™ (zanubrutinib), a new oral treatment for adult patients with mantle cell lymphoma (MCL) who have received at least one prior therapy. “The approval of BRUKINSA as a second-line therapy option for patients … [Read more…]

Rightway Healthcare Secures $20 Million in Series B Financing to Expand its Innovative Healthcare Navigation Platform

Funding Round Led by Thrive Capital Kareem Zaki, General Partner at Thrive Capital, joins Board of Directors NEW YORK–(BUSINESS WIRE)–Rightway Healthcare, a New York-based patient navigation and healthcare advocacy platform for employers and their employees, today announced it secured $20 million in a Series B funding round led by Thrive Capital. The financing will be … [Read more…]